KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Return on Capital Employed (2018 - 2026)

Cardlytics filings provide 9 years of Return on Capital Employed readings, the most recent being 44.57% for Q1 2026.

  • Quarterly Return on Capital Employed rose 2923.0% to 44.57% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 44.57% through Mar 2026, up 2923.0% year-over-year, with the annual reading at 39.04% for FY2025, 1941.0% up from the prior year.
  • Return on Capital Employed hit 44.57% in Q1 2026 for Cardlytics, up from 46.89% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 6.47% in Q1 2022 and bottomed at 96.81% in Q1 2023.
  • Average Return on Capital Employed over 5 years is 55.35%, with a median of 49.72% recorded in 2025.
  • The largest annual shift saw Return on Capital Employed crashed -9034bps in 2023 before it skyrocketed 6041bps in 2024.
  • Cardlytics' Return on Capital Employed stood at 72.68% in 2022, then skyrocketed by 57bps to 31.31% in 2023, then plummeted by -153bps to 79.12% in 2024, then soared by 41bps to 46.89% in 2025, then grew by 5bps to 44.57% in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Return on Capital Employed are 44.57% (Q1 2026), 46.89% (Q4 2025), and 49.72% (Q3 2025).